ARS Pharmaceuticals, Inc. ( SPRY) - Key Metrics
SPRY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.34 | -$0.63 | -$0.61 | -$0.61 |
| 2026Q1 | $0.23 | -$0.61 | -$0.45 | -$0.45 |
| 2025Q4 | $0.28 | -$0.42 | -$0.44 | -$0.44 |
| 2025Q3 | $0.33 | -$0.52 | -$0.48 | -$0.48 |
| 2025Q2 | $0.16 | -$0.46 | -$0.40 | -$0.40 |
SPRY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.18 |
| 2026Q1 | 0% | -3.29 |
| 2025Q4 | 0% | -6.93 |
| 2025Q3 | 0% | -4.83 |
| 2025Q2 | 0% | -9.48 |
SPRY
Price: $5.50
52 week price:
Earnings Per Share: -2.18 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 634.5 million